FDA official logo
GSRS logoPFDA official logo

PEMLIMOGENE MEROLISBAC

UNII:S2EGO8116S
Formula:
Preferred Substance Name:PEMLIMOGENE MEROLISBAC
GSRS Full Record:

  • ADU-214
  • JNJ-64041757
  • LADD LISTERIA MONOCYTOGENES JNJ-64041757
  • LIVE-ATTENUATED LISTERIA MONOCYTOGENES ENCODING EGFRVIII-MESOTHELIN VACCINE JNJ-64041757
  • PEMLIMOGENE MEROLISBAC [INN]
  • PEMLIMOGENE MEROLISBAC [USAN]
  • PEMLIMOGENE MEROLISBAC [WHO-DD]
  • RECOMBINANT LIVE-ATTENUATED DOUBLE-DELETED (LADD) STRAIN OF LISTERIA MONOCYTOGENES (LM .DELTA.ACTA/.DELTA.INLB) EXPRESSING A FUSION PROTEIN COMPRISING THE N-TERMINAL 100 AMINO ACIDS OF THE LM ACTA PROTEIN (ACTAN100), 5 TANDEM COPIES OF A 21 AMINO ACID FRAGMENT OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III (EGFRVIII) AND AMINO ACIDS 35-622 OF HUMAN MESOTHELIN (MSLN), UNDER THE CONTROL THE LM ACTA (ACTIN-ASSEMBLY INDUCING PROTEIN PRECURSOR) PROMOTER, AND CONTAINED WITHIN AN EXPRESSION CASSETTE OF 3874 BP INSERTED AT THE LM TRNAARG LOCUS. BACTERIA GENETICALLY MODIFIED (ANTINEOPLASTIC)



UNII - S2EGO8116S | UNII Search Service